In > 20000 patients spanning 35 countries encompassing most race-ethnicities , we evaluated the incidence of ischemic and hemorrhagic strokes and myocardial infarction in patients within the context of the largest secondary stroke prevention trial ( Prevention Regimen for Effectively Avoiding Secondary Strokes ) to identify any significant differences .